215 related articles for article (PubMed ID: 23219284)
41. Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.
Chrysant SG
Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1115-24. PubMed ID: 24073676
[TBL] [Abstract][Full Text] [Related]
42. Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone.
Fogari R; Corea L; Cardoni O; Cosmi F; Porcellati C; Innocenti P; Provvidenza M; Timio M; Bentivoglio M; Bertocchi F; Zoppi A
J Cardiovasc Pharmacol; 1997 Oct; 30(4):497-503. PubMed ID: 9335410
[TBL] [Abstract][Full Text] [Related]
43. Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial.
Nakao K; Hirata M; Oba K; Yasuno S; Ueshima K; Fujimoto A; Ogihara T; Saruta T;
Hypertens Res; 2010 Jun; 33(6):600-6. PubMed ID: 20379187
[TBL] [Abstract][Full Text] [Related]
44. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
Weber MA; Bakris GL; Hester A; Weir MR; Hua TA; Zappe D; Dahlof B; Velazquez EJ; Pitt B; Jamerson K
Am J Med; 2013 Jun; 126(6):501-8. PubMed ID: 23541376
[TBL] [Abstract][Full Text] [Related]
45. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
46. [Clinical study of the month. The ACCOMPLISH study: challenging the choice of antihypertensive medications in systolic hypertensive patients with high cardiovascular risk].
Krzesinski JM; Scheen AJ
Rev Med Liege; 2009 Feb; 64(2):103-8. PubMed ID: 19370856
[TBL] [Abstract][Full Text] [Related]
47. An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension.
Ueng KC; Lin LC; Voon WC; Lin MC; Liu YB; Su HM; Chang PY; Lin TH; Chen WL; Wu CC; Lai WT; Lin CS
Blood Press Suppl; 2008 Jun; 1():24-31. PubMed ID: 18705532
[TBL] [Abstract][Full Text] [Related]
48. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
[TBL] [Abstract][Full Text] [Related]
49. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
Calhoun DA; Crikelair NA; Yen J; Glazer RD
Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680
[TBL] [Abstract][Full Text] [Related]
50. Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
Drummond W; Sirenko YM; Ramos E; Baek I; Keefe DL
Am J Cardiovasc Drugs; 2011 Oct; 11(5):327-33. PubMed ID: 21846154
[TBL] [Abstract][Full Text] [Related]
51. Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
Ando K; Isshiki M; Takahashi K;
Hypertens Res; 2009 Sep; 32(9):748-52. PubMed ID: 19590506
[TBL] [Abstract][Full Text] [Related]
52. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
Huan Y; Townsend R
Expert Opin Pharmacother; 2012 Nov; 13(16):2409-15. PubMed ID: 23067322
[TBL] [Abstract][Full Text] [Related]
53. Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial.
Lacourcière Y; Taddei S; Konis G; Fang H; Severin T; Zhang J
J Hypertens; 2012 Oct; 30(10):2047-55. PubMed ID: 22828090
[TBL] [Abstract][Full Text] [Related]
54. Antihypertensive and organ-protective effects of benazepril.
Barrios V; Escobar C
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1653-71. PubMed ID: 21108548
[TBL] [Abstract][Full Text] [Related]
55. Comparison of two single-pill dual combination antihypertensive therapies in Chinese patients: a randomized, controlled trial.
Huang QF; Zhang D; Luo Y; Hu K; Wu Q; Qiu H; Xu F; Wang ML; Chen X; Li Y; Wang JG;
BMC Med; 2024 Jan; 22(1):28. PubMed ID: 38263021
[TBL] [Abstract][Full Text] [Related]
56. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
57. Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation.
Hilleman DE; Ryschon KL; Mohiuddin SM; Wurdeman RL
J Hum Hypertens; 1999 Jul; 13(7):477-83. PubMed ID: 10449213
[TBL] [Abstract][Full Text] [Related]
58. Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials.
; Ying A; Arima H; Czernichow S; Woodward M; Huxley R; Turnbull F; Perkovic V; Neal B
Lancet; 2015 Mar; 385(9971):867-74. PubMed ID: 25468168
[TBL] [Abstract][Full Text] [Related]
59. [Is the combination of benazepril and amlodipine more effective in hypertension than the combination of benazepril and hydrochlorothiazide? Results of the ACCOMPLISH trial].
Preobrazhenskiĭ DV
Kardiologiia; 2009; 49(2):81-2. PubMed ID: 19254225
[No Abstract] [Full Text] [Related]
60. Efficacy of combination therapy with amlodipine besylate/benazepril hydrochloride for lowering systolic blood pressure in stage 2 hypertension.
Neutel JM; Smith DH; Weber MA; Schofield L; Purkayastha D; Gatlin M
Am J Geriatr Cardiol; 2006; 15(3):142-50. PubMed ID: 16687966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
